LISA LAMBERTI: Open Payments
NPI 1992794192 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 102 payments from 18 companies in 2025. Trend: 2023 $1,634 · 2024 $1,796 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $437 |
| Janssen Biotech, Inc. | 17 | $305 |
| Aimmune Therapeutics, Inc. | 13 | $296 |
| Gilead Sciences, Inc. | 7 | $112 |
| Celltrion USA Inc. | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Madrigal Pharmaceuticals | 4 | $61 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Biocon Biologics Inc | 2 | $39 |
Products named: TREMFYA, ZENPEP, SKYRIZI, VEGZELMA, RINVOQ, REZDIFFRA, VIBERZI, MAVYRET.
Industry payments across NJ — which companies pay providers there.
